We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVLT
12501
PUT
Datavault AI
DVLT
$272M
$65K ﹤0.01%
4
-2
-33% -$36.7K
VQS
12502
PUT
DELISTED
VIQ SOLUTIONS INC
VQS
$65K ﹤0.01%
+40,000
New +$77K
INFI
12503
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$65K ﹤0.01%
56,800
-9,900
-15% -$11.8K
BGRYW
12504
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
$65K ﹤0.01%
157,888
+201
+0.1% +$112
DOMA
12505
CALL
DELISTED
Doma Holdings, Inc.
DOMA
$65K ﹤0.01%
1,192
-584
-33% -$46.9K
ELVT
12506
DELISTED
Elevate Credit, Inc.
ELVT
$65K ﹤0.01%
21,360
-19,483
-48% -$61.2K
KAIRW
12507
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$65K ﹤0.01%
368,383
-72,840
-17% -$24.7K
EQHA.WS
12508
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$65K ﹤0.01%
188,460
-28,980
-13% -$10.6K
TSPQ.WS
12509
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$65K ﹤0.01%
200,664
+17
+0% +$6
VISL
12510
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$65K ﹤0.01%
3,085
-5,270
-63% -$106K
ALZN icon
12511
CALL
Alzamend Neuro
ALZN
$7.43M
$64K ﹤0.01%
39
-80
-67% -$150K
ASTLW icon
12512
Algoma Steel Group Warrant
ASTLW
$155K
$64K ﹤0.01%
19,619
-6,944
-26% -$17.6K
HLX icon
12513
PUT
Helix Energy Solutions
HLX
$1.54B
$64K ﹤0.01%
13,300
-3,000
-18% -$12.3K
OPTN
12514
DELISTED
OptiNose
OPTN
$64K ﹤0.01%
+1,735
New +$61.9K
MKFG.WS
12515
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$64K ﹤0.01%
101,680
-55,931
-35% -$41K
ENERR
12516
DELISTED
Accretion Acquisition Corp Right
ENERR
$64K ﹤0.01%
400,000
+80,000
+25% +$18K
TRCA.WS
12517
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$64K ﹤0.01%
243,789
+129
+0.1% +$54
LTRPA
12518
PUT
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$64K ﹤0.01%
31,100
-9,200
-23% -$19.5K
GMVD
12519
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$64K ﹤0.01%
+1,434
New +$140K
CDAK
12520
PUT
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$64K ﹤0.01%
+10,200
New +$64K
GHACW
12521
DELISTED
Gaming & Hospitality Acquisition Corp. Warrants
GHACW
$64K ﹤0.01%
214,196
ATAXZ
12522
PUT
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$64K ﹤0.01%
10,600
-14,100
-57% -$85.1K
SLAI
12523
DELISTED
SOLAI Ltd ADS
SLAI
$63K ﹤0.01%
+322
New +$75.7K
CALC icon
12524
CalciMedica
CALC
$20.8M
$63K ﹤0.01%
3,686
-548
-13% -$10.4K
DARE icon
12525
Dare Bioscience
DARE
$13.9M
$63K ﹤0.01%
+3,532
New +$66.8K

Similar funds

Ken Griffin's Q1 2022 Portfolio in Review

As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.